公开(公告)号：US20230037121A1

公开(公告)日：2023-02-02

申请号：US17654236

申请日：2022-03-09

申请人： PEGAVISION CORPORATION

发明人： Hung-Ju CHANG ,  Wei-Jia TING ,  Chi Hao HUANG ,  Hsin-Yi WU

IPC分类号： A61K33/30 ,  A61K9/00 ,  A61K47/02 ,  A61K31/07 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/714 ,  A61K31/375 ,  A61K31/355 ,  A61K31/728 ,  A61K31/7084 ,  A61K31/675 ,  A61P27/04

摘要： Provided is a liquid composition for ophthalmic products. The liquid composition includes a buffer solution and a zinc salt dissolved in the buffer solution. The zinc salt has a weight percentage concentration of 1×10−5% to 3% in the liquid composition. The liquid composition may also include a first vitamin dissolved in the buffer solution. The first vitamin has a weight percentage concentration of 1×10−5% to 1% in the liquid composition. The first vitamin includes vitamin B2, a vitamin B2 derivative, or a combination thereof.